Guijun Wang Selected Research

Guijun Wang Research Topics

Disease

10	Infections 04/2024 - 09/2014
5	Neoplasms (Cancer) 03/2024 - 10/2016
4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 03/2024 - 11/2022
3	Brain Injuries (Brain Injury) 03/2024 - 11/2022
3	Stomach Neoplasms (Stomach Cancer) 03/2024 - 11/2017
3	Inflammation (Inflammations) 12/2023 - 01/2016
2	Stroke (Strokes) 05/2024 - 11/2022
2	Neuroinflammatory Diseases 03/2024 - 12/2023
2	Central Nervous System Diseases (CNS Diseases) 12/2023 - 12/2023
2	Brain Edema (Cerebral Edema) 12/2023 - 11/2022
2	Pancreatitis 01/2018 - 01/2016
1	Iron Overload 05/2024
1	Colorectal Neoplasms (Colorectal Cancer) 02/2024
1	Pulmonary Edema 12/2023
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2023
1	Infarction (Infarctions) 02/2023
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2023
1	Moyamoya Disease (Moya-Moya Disease) 01/2023
1	Ascites 10/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Glioma (Gliomas) 01/2022
1	Virus Diseases (Viral Diseases) 04/2021
1	Hypersensitivity (Allergy) 01/2017
1	Hemolysis 10/2016
1	Bacterial Infections (Bacterial Infection) 09/2014
1	Wounds and Injuries (Trauma) 07/2014
1	Bites and Stings (Sting) 07/2014
1	Thrombosis (Thrombus) 04/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2016
3	IronIBA 05/2024 - 11/2022
3	Caspase 3 (Caspase-3)IBA 03/2024 - 11/2017
3	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2021
2	InflammasomesIBA 03/2024 - 12/2023
2	CateninsIBA 01/2023 - 11/2022
2	Taurine FDA Link 01/2023 - 11/2022
2	yin-chen-hao-tangIBA 01/2018 - 01/2016
1	Hemoglobins (Hemoglobin)IBA 05/2024
1	VimentinIBA 04/2024
1	Cisplatin (Platino)FDA LinkGeneric 03/2024
1	tanshinoneIBA 03/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2024
1	Chimeric Antigen ReceptorsIBA 02/2024
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2024
1	EnzymesIBA 02/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2023
1	ibrutinibIBA 12/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2023
1	Hematoxylin (Haematoxylon)IBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	CXC ChemokinesIBA 12/2023
1	CC ChemokinesIBA 12/2023
1	Secretogranin IIIBA 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 02/2023
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2023
1	Neuroprotective AgentsIBA 11/2022
1	Monoclonal AntibodiesIBA 10/2022
1	Cyclin D1IBA 01/2022
1	CamptothecinIBA 01/2022
1	silvestrolIBA 01/2022
1	AlkaloidsIBA 10/2021
1	lycorineIBA 10/2021
1	PolyphenolsIBA 04/2021
1	TeaIBA 04/2021
1	AntigensIBA 03/2020
1	VaccinesIBA 02/2019
1	DNA VaccinesIBA 01/2018
1	esculetinIBA 11/2017
1	CoumarinsIBA 11/2017
1	Matrix Metalloproteinases (MMPs)IBA 11/2017
1	Cytochromes c (Cytochrome c)IBA 11/2017
1	Caspase 9IBA 11/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	NocodazoleIBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Docetaxel (Taxotere)FDA Link 10/2016
1	Polysorbates (PSML)FDA Link 10/2016
1	LipidsIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 09/2014
1	Messenger RNA (mRNA)IBA 09/2014
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 09/2014
1	16S Ribosomal RNAIBA 07/2014
1	Factor Xa (Coagulation Factor Xa)IBA 04/2009
1	Factor VIIa (Activated Factor VII)IBA 04/2009
1	Thrombin FDA Link 04/2009
1	Blood Coagulation Factors (Coagulation Factor)IBA 04/2009

Therapy/Procedure

2	Therapeutics 03/2024 - 10/2023
1	Drug Therapy (Chemotherapy) 01/2018